These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2514532)

  • 1. [The effect of an immune antibacterial plasma and a donor leukocyte mass on the immune system of patients with suppurative-septic processes].
    Bulava GV; Zdanovskaia LK; Titova TI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Oct; (10):91-6. PubMed ID: 2514532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
    Nazarchuk LV; Fedorovskaia EA
    Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. IV. The effect of immunization with Pseudomonas aeruginosa vaccine on the immune status of volunteer donors].
    Titova TI; Sidorova TN; Radkevich SA; Antsiferova NG; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):80-4. PubMed ID: 3933225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa and Proteus antigenemia and antibody formation in mono- and mixed infections in patients with suppurative inflammatory diseases].
    Bulava GV; Men'shikov DD; Khvatov VB
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):63-7. PubMed ID: 3107287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
    Bulava GV; Ermolin GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular and humoral immunity of volunteers consuming diets with various protein levels].
    Voĭtko NE; Iatsyshina TA; Vysotskiĭ VG; Konovalova LS
    Vopr Pitan; 1985; (3):28-33. PubMed ID: 3875930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoenzyme method of diagnosing suppurative-septic complications due to Pseudomonas aeruginosa and Proteus].
    Bulava GV; Ermolin GA; Grigor'ev NI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):89-93. PubMed ID: 6431720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotics on the formation of specific antibodies.
    Lochmann O; Janovská D; Výmola F; Svanodová E
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):220-5. PubMed ID: 119810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation].
    Nazarchuk LV
    Vrach Delo; 1987 Jul; (7):96-8. PubMed ID: 3114958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of bacterial antigens on the functional capacity of immunocompetent cells].
    Savitskaia KI; Solodilova OE
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):69-72. PubMed ID: 3937395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis.
    Senior BW; McBride PD; Morley KD; Kerr MA
    J Med Microbiol; 1995 Sep; 43(3):176-84. PubMed ID: 7650724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of T- and B-system lymphocytes in generalized purulent infections].
    Malafeeva EV; Romanov VA; Belokurov IuN; Gramenitskiĭ AB
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):39-42. PubMed ID: 7023144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Gram-negative infection by 'super-active' antigen.
    Roe EA
    Immunology; 1976 Nov; 31(5):707-15. PubMed ID: 825449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
    Høiby N; Hertz JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.
    Jakab GJ
    Infect Immun; 1976 Aug; 14(2):389-98. PubMed ID: 9364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].
    Aleksandrova IA; Titova TI; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):46-50. PubMed ID: 2496541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa].
    Nazarchuk LV
    Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
    Pier GB; Thomas DM
    J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.